Buy Retatrutide Peptide in Australia
Buy Retatrutide in Australia from Macropus Peptides in four strengths: Retatrutide 10mg, 15mg, 20mg and 30mg. Every vial contains research-grade Retatrutide as a lyophilised powder, sealed under a crimped cap and labelled with compound, strength, lot number and storage temperature, with a certificate of analysis issued for each lot. Retatrutide 10mg suits a first order, while the 20mg and 30mg vials give the lowest Retatrutide price per milligram for longer studies. All strengths come from the same controlled supply, so moving from one vial size to another changes only the quantity. Order Retatrutide online, add bacteriostatic water for reconstitution, and your parcel is dispatched from local Australian stock to any address in the country. Retatrutide for sale Australia wide to researchers aged 18 and over, strictly for in-vitro laboratory research and not for human or veterinary use.
| Compound | Retatrutide |
|---|---|
| Amount | 10 mg |
| Form | Lyophilised powder |
| Category | Metabolic research |
| Storage | -20 °C, protect from light |
| Testing | HPLC purity and mass spectrometry identity, every batch |
| Certificate of analysis | Available for every lot, matched to the lot number on the label |
Retatrutide 10mg vial
Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.
Buy Retatrutide Australia: 10mg, 15mg, 20mg and 30mg Vials
Macropus Peptides supplies this peptide across Australia in four vial strengths: 10mg, 15mg, 20mg and 30mg. It is a research peptide in late-stage clinical study, and we supply it as research-grade lyophilised powder for laboratory use. Every strength comes from the same controlled supply and is released by lot, so the only difference between vials is the amount of Retatrutide inside and the price per milligram.
Retatrutide Australia: what is Retatrutide
Retatrutide, known in development as LY3437943, is a synthetic peptide created for metabolic research. It is built to act on three hormone receptors the body uses to manage blood sugar, appetite and energy use: the GLP-1 receptor, the GIP receptor and the glucagon receptor. Most compounds in this class act on one or two of these receptors. Retatrutide acts on all three from a single molecule, which is why it is described as a triple agonist. It is now in phase 3 clinical trials and has become one of the most closely studied new peptides in metabolic science, which is why laboratories in Australia and overseas want access to research-grade material.
Retatrutide peptide Australia: how Retatrutide works in research
GLP-1 and GIP are hormones released from the gut after eating. Both increase insulin release when blood glucose is high, and GLP-1 also slows stomach emptying and acts on appetite centres in the brain. Glucagon works in the opposite direction on the liver, raising glucose output, and it also increases how much fat the liver burns for energy. Retatrutide combines all three signals, with its strongest activity at the GIP receptor. Two design features make that possible in one molecule: modified amino acids that stop the enzymes which normally break these hormones down within minutes, and a fatty acid chain that binds to albumin in the blood, giving a half-life of about six days in human studies. In the laboratory, researchers use Retatrutide to study how the three signals interact and what the glucagon component adds compared with single and dual agonists.
Retatrutide clinical trials: what the research shows
Retatrutide has an unusually strong published record for a peptide still in development. Its discovery and first human data were published in Cell Metabolism in 2022, followed the same year by a phase 1b study in type 2 diabetes in The Lancet. In 2023, two phase 2 trials were published: a 48-week trial in 338 adults with obesity in the New England Journal of Medicine, and a 36-week trial in adults with type 2 diabetes in The Lancet. A further study in Nature Medicine in 2024 examined liver fat. These trials measured body weight, blood glucose control and liver fat, and their results moved Retatrutide into a large phase 3 programme that is still under way. Every study is listed with its design and what it measured in our Retatrutide research studies library.
Retatrutide vial specifications
| Specification | Detail |
|---|---|
| Compound | Retatrutide |
| Amount | 10 mg |
| Form | Lyophilised powder |
| Category | Metabolic research |
| Storage | -20 °C, protect from light |
Each vial contains Retatrutide as a dry, white lyophilised powder in a sealed glass vial. The printed label shows the compound name, strength, lot number and storage temperature. Send us that lot number for the matching certificate of analysis, so every vial you receive is traceable to its batch.
Retatrutide price and Retatrutide cost in Australia
| Strength | Price | Price per mg |
|---|---|---|
| Retatrutide 10mg | $159.99 | $16.00 per mg |
| Retatrutide 15mg | $209.99 | $14.00 per mg |
| Retatrutide 20mg | $249.99 | $12.50 per mg |
| Retatrutide 30mg | $369.99 | $12.33 per mg |
Each vial is priced in Australian dollars, and the cost per milligram falls as the strength goes up. The 10mg vial carries the highest cost per milligram, the 15mg vial is lower, and the 20mg and 30mg vials are the most economical. If your work will use more than one 10mg vial, a larger strength is the better value.
Retatrutide 10mg: where to buy in Australia
The 10mg vial is the strength most people search for by name. It contains 10 milligrams of peptide, enough to set up and validate a laboratory protocol on a single lot without committing to a larger vial. Mixed with 2 mL of bacteriostatic water it makes a 5 mg per mL stock; with 1 mL it gives 10 mg per mL.
Retatrutide 15mg: more peptide at a lower cost per mg
The 15mg vial holds half as much again as the 10mg vial and costs less per milligram. It suits work that runs slightly past a single 10mg vial and needs to stay on one lot number. Reconstituted with 3 mL, it gives the same 5 mg per mL stock as the 10mg vial, so volumes already worked out for 10mg carry straight across.
Retatrutide 20mg: double the 10mg vial for better value
The 20mg vial contains twice the peptide of the 10mg vial at well under twice the price, which makes it the best-value choice once a protocol is established. Adding 2 mL makes a 10 mg per mL stock, and 4 mL makes 5 mg per mL.
Retatrutide 30mg: the lowest Retatrutide price per milligram
The 30mg vial is our largest and carries the lowest cost per milligram in the range. It is chosen for long or multi-part studies that must run from a single lot, because changing lots partway through adds a variable to your results. Reconstituted with 3 mL it gives a 10 mg per mL stock.
Best place to buy Retatrutide Australia
- Four strengths, 10mg, 15mg, 20mg and 30mg, from one controlled supply
- A fixed price on every vial, with the cost per milligram falling as the strength rises
- Lot number printed on every label, with a certificate of analysis for each lot
- Sealed vials packed upright with the cap protected
- Stock held in Australia and dispatched from Australian stock
Retatrutide how to get: buy Retatrutide online
- Choose Retatrutide 10mg, 15mg, 20mg or 30mg
- Select the number of vials and add them to your cart
- Add bacteriostatic water if you need it for reconstitution
- Complete checkout, confirming you are 18 or over and buying for research
- Receive your parcel from our Australian shelves and request the certificate for your lot
Retatrutide calculator: how much bac water for 10mg and 20mg
Every order comes with access to our Retatrutide calculator, which converts the volume of bacteriostatic water you add into milligrams and micrograms per millilitre for the strength you bought. As a guide, 2 mL gives 5 mg per mL in the 10mg vial and 10 mg per mL in the 20mg vial. Add bacteriostatic water 10mL to the same order so both arrive together; other diluents and kits are in lab supplies and kits.
Is Retatrutide available in Australia
Yes, as a research peptide. It is not registered as a medicine in Australia and has no TGA approval, so it is only supplied for in-vitro laboratory research, which is how Macropus Peptides sells it. When Retatrutide will be available in Australia as a prescribed product depends on the clinical trials finishing and a TGA evaluation, and no date has been set. Scheduling for research peptides is decided by the TGA, so confirm how the current Poisons Standard applies to your organisation before ordering.
Retatrutide for sale Australia wide: delivery from inside Australia
Every order is packed and dispatched from our Australian facility to Melbourne, Brisbane, Perth, Adelaide, Hobart, Darwin, Canberra and regional addresses. Because the stock is already in Australia, there is no international shipping or customs delay. Related peptides such as Cagrilintide and MOTS-C are in our metabolic research range.
References
- LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept. Cell Metabolism. 2022;34(9):1234-1247.
- Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial. New England Journal of Medicine. 2023;389(6):514-526.
- Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA. The Lancet. 2023;402(10401):529-544.
Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.